Literature DB >> 18509091

Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients.

Sridhar Chaganti1, Cindy S Ma, Andrew I Bell, Debbie Croom-Carter, Andrew D Hislop, Stuart G Tangye, Alan B Rickinson.   

Abstract

Epstein-Barr virus (EBV) persists in healthy virus carriers within the immunoglobulin (Ig)D(-)CD27(+) (class-switched) memory B-cell compartment that normally arises through antigen stimulation and germinal center transit. Patients with X-linked lymphoproliferative disease (XLP) lack such class-switched memory B cells but are highly susceptible to EBV infection, often developing fatal symptoms resembling those seen in EBV-associated hemophagocytic syndrome (EBV-AHS), a disease caused by aberrant virus entry into the NK- or T-cell system. Here we show that XLP patients who survive primary EBV exposure carry relatively high virus loads in the B-cell, but not the NK- or T-cell, compartment. Interestingly, in the absence of conventional class-switched memory B cells, the circulating EBV load was concentrated within a small population of IgM(+)IgD(+)CD27(+) (nonswitched) memory cells rather than within the numerically dominant naive (IgM(+)IgD(+)CD27(-)) or transitional (CD10(+)CD27(-)) subsets. In 2 prospectively studied patients, the circulating EBV load was stable and markers of virus polymorphism detected the same resident strain over time. These results provide the first definitive evidence that EBV can establish persistence in the B-cell system in the absence of fully functional germinal center activity and of a class-switched memory B-cell compartment.

Entities:  

Mesh:

Year:  2008        PMID: 18509091     DOI: 10.1182/blood-2007-10-116269

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.

Authors:  B Tóth; B Soltész; E Gyimesi; G Csorba; Á Veres; Á Lányi; G Kovács; L Maródi; M Erdős
Journal:  J Clin Immunol       Date:  2014-12-10       Impact factor: 8.317

2.  Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment.

Authors:  Silvia Della Bella; Adriano Taddeo; Elena Colombo; Lucia Brambilla; Monica Bellinvia; Fabrizio Pregliasco; Monica Cappelletti; Maria Luisa Calabrò; Maria Luisa Villa
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 3.  The pathogenesis of Epstein-Barr virus persistent infection.

Authors:  David A Thorley-Lawson; Jared B Hawkins; Sean I Tracy; Michael Shapiro
Journal:  Curr Opin Virol       Date:  2013-05-15       Impact factor: 7.090

4.  Exosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells.

Authors:  Cindy Gutzeit; Noemi Nagy; Maurizio Gentile; Katarina Lyberg; Janine Gumz; Helen Vallhov; Irene Puga; Eva Klein; Susanne Gabrielsson; Andrea Cerutti; Annika Scheynius
Journal:  J Immunol       Date:  2014-05-14       Impact factor: 5.422

5.  The intersection of Epstein-Barr virus with the germinal center.

Authors:  Jill E Roughan; David A Thorley-Lawson
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

Review 6.  How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.

Authors:  Ole Haagen Nielsen; Eric Charles LaCasse
Journal:  Genet Med       Date:  2016-07-14       Impact factor: 8.822

7.  Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.

Authors:  Umaimainthan Palendira; Carol Low; Andrew I Bell; Cindy S Ma; Rachel J M Abbott; Tri Giang Phan; D Sean Riminton; Sharon Choo; Joanne M Smart; Vassilios Lougaris; Silvia Giliani; Rebecca H Buckley; Bodo Grimbacher; Frank Alvaro; Amy D Klion; Kim E Nichols; Stephen Adelstein; Alan B Rickinson; Stuart G Tangye
Journal:  J Exp Med       Date:  2012-04-09       Impact factor: 14.307

8.  Central nervous system involvement of epstein barr virus associated lymphoproliferative disorder in a child with acute lymphoblastic leukemia: successful treatment with rituximab and interferon-alpha.

Authors:  Berna Atabay; Meral Türker; Can Oztürk; Sümer Sütçüoğlu; Haldun Oniz; Esra Arun Ozer
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

9.  An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Authors:  Gemma L Kelly; Heather M Long; Julianna Stylianou; Wendy A Thomas; Alison Leese; Andrew I Bell; Georg W Bornkamm; Josef Mautner; Alan B Rickinson; Martin Rowe
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

10.  The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.

Authors:  James Heather; Kirsty Flower; Samine Isaac; Alison J Sinclair
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.